Monoethanolamine Palmitic Acid Amide
Monoethanolamine Palmitic Acid Amide Uses, Dosage, Side Effects, Food Interaction and all others data.
A cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection. Monoethanolamine Palmitic Acid Amide is available for human use as a supplement (400 mg capsules) and as food for medical purposes In Italy and Spain (300 mg and 600 mg tablets).
| Trade Name | Monoethanolamine Palmitic Acid Amide |
| Generic | Palmidrol |
| Palmidrol Other Names | Hydroxyethylpalmitamide, Monoethanolamine palmitic acid amide, N-hexadecanoylethanolamine, N-palmitoylethanolamine, Palmidrol, palmidrolum, Palmitamide MEA, Palmitic acid monoethanolamide, Palmitinsaeure-beta-hydroxyethylamid, Palmitoyl ethanolamide, Palmitoyl-EA, Palmitoylethanolamide |
| Type | |
| Formula | C18H37NO2 |
| Weight | Average: 299.4919 Monoisotopic: 299.282429433 |
| Groups | Experimental, Nutraceutical |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Monoethanolamine Palmitic Acid Amide
